Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial

Press/Media: Press / Media

PeriodApr 13 2017 → Apr 14 2017

Media coverage

20

Media coverage

  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPipelineReview
    CountrySpain
    Date4/14/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date4/14/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPR Newswire
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletMorningstar.com
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPR Newswire
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletCanada NewsWire
    CountryCanada
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletCanada NewsWire
    CountryCanada
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPR Newswire
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletWorldNetDaily
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletBioSpace
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletYahoo! Finance
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPharmiWeb
    CountryUnited Kingdom
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletBiotechgate
    CountrySwitzerland
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletIndia Pharma News
    CountryIndia
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletUSA Life Sciences Database
    CountrySwitzerland
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPharmacy Choice
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletPharmaVOICE
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletKMOV.com
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletWOWK
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd
  • TitleMedicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
    Media name/outletKTVN
    CountryUnited States
    Date4/13/17
    PersonsAndrew Brenner, John R Floyd